Drug
Mirabegron
Mirabegron: highest development phase Phase 1, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| mirabegron NCT01489696 | Phase 1 | Cardiovascular |
Latest
No recent events.
Follow Mirabegron on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.